Literature DB >> 14589517

Lateralized brain damage and performance on trail making A and B, Digit Span Forward and Backward, and TPT Memory and Location.

R L Heilbronner1, G K Henry, P Buck, R L Adams, T Fogle.   

Abstract

The present retrospective study was undertaken to determine whether Trail Making Test A and B, Digit Span Forward and Backward, and TPT Memory and Location scores are differentially sensitive to right or left hemisphere brain damage. Groups of patients with right, left, and generalized cerebral lesions and matched normal controls were compared. Results showed a relative failure for any individual measure, difference, or ratio score to reliably distinguish between right and left hemisphere lesions. Patients with diffuse lesions performed significantly worse than non-neurologic medical controls and right and left lesion groups on Trails A and TPT Memory and Location. Results are discussed in terms of specific methodological variables including chronicity of lesion, the nature of the task demands, and priming effects.

Entities:  

Year:  1991        PMID: 14589517

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  3 in total

1.  Performance of Individuals with Left-Hemisphere Stroke and Aphasia and Individuals with Right Brain Damage on Forward and Backward Digit Span Tasks.

Authors:  Jacqueline Laures-Gore; Rebecca Shisler Marshall; Erin Verner
Journal:  Aphasiology       Date:  2011-01-14       Impact factor: 2.773

2.  The influence of cognitive control on the processing of L2 garden path sentence among Chinese-English bilinguals.

Authors:  Zhilong Xie; Guofang Zeng; Shuya Zhou; Juan Wang
Journal:  Front Behav Neurosci       Date:  2022-09-23       Impact factor: 3.617

3.  Tablet-Based Functional MRI of the Trail Making Test: Effect of Tablet Interaction Mode.

Authors:  Mahta Karimpoor; Nathan W Churchill; Fred Tam; Corinne E Fischer; Tom A Schweizer; Simon J Graham
Journal:  Front Hum Neurosci       Date:  2017-10-24       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.